Patient iP is a first-to-market clinical trial matching platform that enables CROs, life sciences companies, and networked study sites to query de-identified, aggregated electronic health record data against discrete study protocols. The platform loads inclusion and exclusion criteria and identifies matched patients and their sites to initiate accrual and support early feasibility modeling. Founded in 2014 and based in Rochester, NY, the company has completed platform development and launched multiple clinical trial study sites. Patient iP recently received a letter of commitment from one of the largest global CROs, demonstrating early commercial traction. The company closed a $2 million Series A to accelerate sales and marketing and to expand its implementation team. CEO Michael J. Margiotta, founder and former CEO of eHealthTechnologies, leads the business.

Total raised

$2M

Funding rounds

1

Latest round

Series A

Latest activity

Jan 2016